Ganymed Pharmaceuticals News
Most Popular Ganymed Pharmaceuticals Story
Ganymed gains $82M in new round
ATS Beteiligungsverwaltung has led an $82 million (€65 million) round for Germany's Ganymed Pharmaceuticals. Future Capital joined the round with private investors as Ganymed prepares to enter Read more...
Latest Headlines
- November 18, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
